CNS Response: The key to informed mental health treatment

About Us

CNS Response is the first company to discover the basis for matching mental and addiction patient physiology to treatment outcome (a biomarker system), thereby fundamentally altering the treatment of neuropsychiatric illness.

CNS Response has developed a robust, proven technology to assess the presence of individual neurophysiologic abnormalities and to guide subsequent psychiatric treatment with an astonishing 80% effectiveness in retrospective and prospective studies and in managed care, outpatient psychiatric and residential substance abuse clinical settings. Referenced-EEG (rEEG^®) is a patented technology that utilizes common electroencephalography (EEG) in conjunction with a normative database and a proprietary clinical (symptomatic) database to identify abnormal patient physiology. Appropriate medications are then selected specifically to normalize discovered abnormalities based upon proprietary treatment algorithms.

The CNS Response technology also has numerous applications in CNS drug discovery and development, a field which has been plagued by the same lack of physiologic markers as clinical psychiatric care. rEEG can be used to stratify study populations to improve the success of FDA clinical trials, to provide insight on effective therapeutic dosing of investigational drugs, to identify additional indications for psychiatric medications, to provide insight into effective drug combinations, and to identify psychiatric indications for non-psychiatric medications.

Recent News